{"id":351932,"date":"2025-08-26T06:21:55","date_gmt":"2025-08-26T06:21:55","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-glaukos-corporation\/"},"modified":"2025-09-10T21:02:57","modified_gmt":"2025-09-10T21:02:57","slug":"how-to-buy-glaukos-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/","title":{"rendered":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334045,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351932","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131"},"description":"Glaukos Corporation (GKOS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i oftalmik \u015firkete nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Glaukos Corporation (GKOS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i oftalmik \u015firkete nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"G\u00f6z bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Glaukos Corporation (GKOS), t\u0131bbi yenili\u011fi g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeliyle birle\u015ftiriyor\u2014geleneksel sa\u011fl\u0131k hisselerinin \u00f6tesine bakmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Glokom tedavisini d\u00f6n\u00fc\u015ft\u00fcren iDose TR gibi \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnlerle, bu \u015firket milyonlarca hayat\u0131 etkilerken hissedar de\u011feri yarat\u0131yor. GKOS'a yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"G\u00f6z bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Glaukos Corporation (GKOS), t\u0131bbi yenili\u011fi g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme potansiyeliyle birle\u015ftiriyor\u2014geleneksel sa\u011fl\u0131k hisselerinin \u00f6tesine bakmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Glokom tedavisini d\u00f6n\u00fc\u015ft\u00fcren iDose TR gibi \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnlerle, bu \u015firket milyonlarca hayat\u0131 etkilerken hissedar de\u011feri yarat\u0131yor. GKOS'a yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Glaukos Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2> <p>10 Eyl\u00fcl 2025 itibar\u0131yla, Glaukos Corporation (GKOS) NYSE'de 90,91$ seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: 3 Kas\u0131m 2025 kesinlikle kritik\u2014Glaukos, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirmi\u015ftir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 GKOS Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>30 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>94,50$<\/td><td>%8,2 Art\u0131\u015f (1 hafta)<\/td><\/tr> <tr><td>30 Nis 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>88,20$<\/td><td>%12,5 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td><\/tr> <tr><td>\u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>102,30$<\/td><td>%15,3 D\u00fc\u015f\u00fc\u015f (k\u00e2rl\u0131l\u0131k endi\u015feleri)<\/td><\/tr> <tr><td>Kas 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>95,80$<\/td><td>%6,8 Art\u0131\u015f (iDose TR heyecan\u0131)<\/td><\/tr> <tr><td>A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>89,40$<\/td><td>%4,2 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>May 2024<\/td><td>FDA Onay\u0131<\/td><td>82,10$<\/td><td>%18,9 Art\u0131\u015f (reg\u00fclasyon zaferi)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri (\u00f6rne\u011fin 2. \u00e7eyrek 2025) patlay\u0131c\u0131 yukar\u0131 hareketler yarat\u0131r. Hisse, tahminleri %7,4 a\u015fan rekor 124,1 milyon $ gelir raporunun ard\u0131ndan %8,2 s\u0131\u00e7rad\u0131. Ancak, k\u00e2rl\u0131l\u0131k endi\u015feleri \u015eubat 2025'te keskin d\u00fc\u015f\u00fc\u015flere neden olabilir.<\/p> <h3>6 Ayl\u0131k Fiyat Seyri (Mart-Eyl\u00fcl 2025)<\/h3> <p>Glaukos hisseleri \u00f6nemli volatilite ya\u015fad\u0131, y\u0131lba\u015f\u0131ndan bu yana yakla\u015f\u0131k %37-40 d\u00fc\u015ft\u00fc ancak son zamanlarda istikrar g\u00f6steriyor:<\/p> <ul> <li><strong>Mart<\/strong>: 125$+ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 y\u00fckseli\u015f)<\/li> <li><strong>May\u0131s<\/strong>: 95-100$ (k\u00e2r realizasyonu d\u00f6nemi)<\/li> <li><strong>Temmuz<\/strong>: 90-95$ (2. \u00e7eyrek kazan\u00e7 haz\u0131rl\u0131\u011f\u0131)<\/li> <li><strong>Eyl\u00fcl<\/strong>: 90,91$ (destek bulma)<\/li> <\/ul> <p>Bu dramatik hareketin sebebi nedir? Hisse 23 Ocak 2025'te t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 163,71$'a ula\u015ft\u0131, ancak k\u00e2rl\u0131l\u0131k zamanlamas\u0131 ve MAC geri \u00f6deme sorunlar\u0131 nedeniyle g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesine ra\u011fmen sat\u0131\u015f bask\u0131s\u0131 olu\u015ftu.<\/p> <h3>Ana Etkenler<\/h3> <ul> <li>iDose TR yakla\u015f\u0131k 31 milyon $ \u00e7eyreklik sat\u0131\u015f \u00fcretiyor<\/li> <li>%30 y\u0131ll\u0131k gelir b\u00fcy\u00fcmesi<\/li> <li>\u00c7ift b\u00fcy\u00fcme motorlu i\u015f modeline ge\u00e7i\u015f<\/li> <\/ul> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 (Y\u0131l Sonu)<\/strong>: 127-131$ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br> 480-486 milyon $ gelir rehberli\u011fi y\u00fckseltildi ve g\u00fc\u00e7l\u00fc iDose TR benimsemesi ile analistler y\u0131l sonuna kadar %35-39 yukar\u0131 potansiyel g\u00f6r\u00fcyor.<\/li> <li><strong>2026<\/strong>: 145-155$<br> iDose TR pazar penetrasyonunun devam\u0131 ve potansiyel FDA onaylar\u0131 b\u00fcy\u00fcmeyi destekliyor.<\/li> <li><strong>2028<\/strong>: 180-210$<br> Giri\u015fimsel glokom alan\u0131nda pazar liderli\u011fi peki\u015ftiriliyor.<\/li> <li><strong>2030<\/strong>: 250-300$<br> K\u00fcresel geni\u015fleme ve yeni \u00fcr\u00fcn hatt\u0131 ticarile\u015ftirmesi.<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Mevcut fiyat\u0131n i\u00e7sel de\u011fere %43 iskonto ile i\u015flem g\u00f6rmesi, uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc bir al\u0131m f\u0131rsat\u0131 sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>K\u00e2rl\u0131l\u0131k zamanlamas\u0131<\/strong>: H\u00e2l\u00e2 net zarar bildiriyor (-0,34$ GAAP EPS 2. \u00e7eyrekte)<\/li> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Baz\u0131 b\u00f6lgelerde MAC geri \u00f6deme sorunlar\u0131<\/li> <li><strong>Pazar rekabeti<\/strong>: Oftalmoloji alan\u0131nda yerle\u015fik oyuncular<\/li> <li><strong>Volatilite<\/strong>: Beta 0,77 ancak Ocak zirvelerinden %44 d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Rekor b\u00fcy\u00fcme<\/strong>: Y\u0131ll\u0131k %30 gelir art\u0131\u015f\u0131 ile 124,1 milyon $<\/li> <li><strong>\u00dcr\u00fcn ba\u015far\u0131s\u0131<\/strong>: iDose TR yakla\u015f\u0131k 31 milyon $ \u00e7eyreklik sat\u0131\u015fla b\u00fcy\u00fck benimseme sa\u011fl\u0131yor<\/li> <li><strong>Rehberlik y\u00fckseltmesi<\/strong>: Y\u0131l sonu gelir tahmini 480-486 milyon $ olarak art\u0131r\u0131ld\u0131<\/li> <li><strong>Pazar liderli\u011fi<\/strong>: 1,64 milyar $\u2019l\u0131k k\u00fcresel glokom pazar\u0131nda \u00f6nc\u00fc<\/li> <li><strong>G\u00fc\u00e7l\u00fc nakit<\/strong>: 500 milyon $ rezerv stratejik esneklik sa\u011fl\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Ortalama maliyetle al\u0131m<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 3 Kas\u0131m\u2019\u0131 yak\u0131ndan takip edin\u2014kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015flerde al\u0131m yap\u0131n<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir b\u00fcy\u00fcme hikayesi, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li> <li><strong>Do\u011fru \u00e7e\u015fitlendirin<\/strong>: GKOS pay\u0131n\u0131z\u0131 portf\u00f6y\u00fcn\u00fcz\u00fcn %10\u2019unun alt\u0131nda tutun<\/li> <\/ol> <p>Esprili bir yorum: \"GKOS ticareti g\u00f6z ameliyat\u0131 gibidir\u2014sabit eller ve m\u00fckemmel zamanlama gerektirir. Yanl\u0131\u015f anda k\u0131rparsan\u0131z f\u0131rsat\u0131 ka\u00e7\u0131rabilirsiniz!\"<\/p> <h2>\u2705 Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"GKOS\" aramas\u0131 yap\u0131n<\/td><td>Sadece \"Glaukos\" de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131 ve toplam maliyeti i\u015flem \u00f6ncesi kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito<\/strong>: Sadece 5$ ile portf\u00f6y\u00fcn\u00fcz\u00fc olu\u015fturmaya ba\u015flayabilirsiniz<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong>: Herhangi bir kimlik belgesi ile 1 dakikal\u0131k KYC<\/li> <li><strong>100+ para \u00e7ekme se\u00e7ene\u011fi<\/strong>: Kripto para ve d\u00fcnya \u00e7ap\u0131nda banka transferleri dahil<\/li> <li><strong>Par\u00e7al\u0131 hisseler<\/strong>: Pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yapabilirsiniz<\/li> <\/ul> <h2>\ud83c\udf0d 2025\u2019te Glaukos: G\u00f6z Bak\u0131m\u0131nda Devrim<\/h2> <p>Glaukos Corporation, glokom, kornea bozukluklar\u0131 ve retina hastal\u0131klar\u0131n\u0131 hedefleyen be\u015f yenilik\u00e7i platformla oftalmoloji alan\u0131nda liderdir. \u015eirket, Mikro-\u0130nvaziv Glokom Cerrahisi (MIGS) \u00f6nc\u00fcs\u00fcd\u00fcr ve 1,64 milyar $\u2019l\u0131k k\u00fcresel glokom pazar\u0131nda liderli\u011fini s\u00fcrd\u00fcrmektedir.<\/p> <p><strong>2025 E\u011flenceli Ger\u00e7ek<\/strong>: Glaukos\u2019un iDose TR implant\u0131 \u00f6yle bir at\u0131l\u0131m ki, hacmin %80\u2019den fazlas\u0131 profesyonel \u00fccret tarifelerinin yerle\u015fik oldu\u011fu b\u00f6lgelerden geliyor\u2014cerrahlar, glokom hastalar\u0131 i\u00e7in g\u00fcnl\u00fck g\u00f6z damlas\u0131n\u0131 ortadan kald\u0131ran bu damlas\u0131z tedaviyi kullanmak i\u00e7in adeta s\u0131raya giriyor!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Glaukos Hissesi: G\u00fcncel Fiyat ve Piyasa Konumu<\/h2>\n<p>10 Eyl\u00fcl 2025 itibar\u0131yla, Glaukos Corporation (GKOS) NYSE&#8217;de 90,91$ seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: 3 Kas\u0131m 2025 kesinlikle kritik\u2014Glaukos, piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Tarihsel olarak, bu raporlar fiyatlar\u0131 dramatik \u015fekilde hareket ettirmi\u015ftir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 GKOS Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>94,50$<\/td>\n<td>%8,2 Art\u0131\u015f (1 hafta)<\/td>\n<\/tr>\n<tr>\n<td>30 Nis 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>88,20$<\/td>\n<td>%12,5 Art\u0131\u015f (tahminleri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>\u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>102,30$<\/td>\n<td>%15,3 D\u00fc\u015f\u00fc\u015f (k\u00e2rl\u0131l\u0131k endi\u015feleri)<\/td>\n<\/tr>\n<tr>\n<td>Kas 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>95,80$<\/td>\n<td>%6,8 Art\u0131\u015f (iDose TR heyecan\u0131)<\/td>\n<\/tr>\n<tr>\n<td>A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>89,40$<\/td>\n<td>%4,2 D\u00fc\u015f\u00fc\u015f (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>May 2024<\/td>\n<td>FDA Onay\u0131<\/td>\n<td>82,10$<\/td>\n<td>%18,9 Art\u0131\u015f (reg\u00fclasyon zaferi)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Analizi<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri (\u00f6rne\u011fin 2. \u00e7eyrek 2025) patlay\u0131c\u0131 yukar\u0131 hareketler yarat\u0131r. Hisse, tahminleri %7,4 a\u015fan rekor 124,1 milyon $ gelir raporunun ard\u0131ndan %8,2 s\u0131\u00e7rad\u0131. Ancak, k\u00e2rl\u0131l\u0131k endi\u015feleri \u015eubat 2025&#8217;te keskin d\u00fc\u015f\u00fc\u015flere neden olabilir.<\/p>\n<h3>6 Ayl\u0131k Fiyat Seyri (Mart-Eyl\u00fcl 2025)<\/h3>\n<p>Glaukos hisseleri \u00f6nemli volatilite ya\u015fad\u0131, y\u0131lba\u015f\u0131ndan bu yana yakla\u015f\u0131k %37-40 d\u00fc\u015ft\u00fc ancak son zamanlarda istikrar g\u00f6steriyor:<\/p>\n<ul>\n<li><strong>Mart<\/strong>: 125$+ (1. \u00e7eyrek kazan\u00e7 sonras\u0131 y\u00fckseli\u015f)<\/li>\n<li><strong>May\u0131s<\/strong>: 95-100$ (k\u00e2r realizasyonu d\u00f6nemi)<\/li>\n<li><strong>Temmuz<\/strong>: 90-95$ (2. \u00e7eyrek kazan\u00e7 haz\u0131rl\u0131\u011f\u0131)<\/li>\n<li><strong>Eyl\u00fcl<\/strong>: 90,91$ (destek bulma)<\/li>\n<\/ul>\n<p>Bu dramatik hareketin sebebi nedir? Hisse 23 Ocak 2025&#8217;te t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 163,71$&#8217;a ula\u015ft\u0131, ancak k\u00e2rl\u0131l\u0131k zamanlamas\u0131 ve MAC geri \u00f6deme sorunlar\u0131 nedeniyle g\u00fc\u00e7l\u00fc gelir b\u00fcy\u00fcmesine ra\u011fmen sat\u0131\u015f bask\u0131s\u0131 olu\u015ftu.<\/p>\n<h3>Ana Etkenler<\/h3>\n<ul>\n<li>iDose TR yakla\u015f\u0131k 31 milyon $ \u00e7eyreklik sat\u0131\u015f \u00fcretiyor<\/li>\n<li>%30 y\u0131ll\u0131k gelir b\u00fcy\u00fcmesi<\/li>\n<li>\u00c7ift b\u00fcy\u00fcme motorlu i\u015f modeline ge\u00e7i\u015f<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu)<\/strong>: 127-131$ \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> 480-486 milyon $ gelir rehberli\u011fi y\u00fckseltildi ve g\u00fc\u00e7l\u00fc iDose TR benimsemesi ile analistler y\u0131l sonuna kadar %35-39 yukar\u0131 potansiyel g\u00f6r\u00fcyor.<\/li>\n<li><strong>2026<\/strong>: 145-155$<br \/> iDose TR pazar penetrasyonunun devam\u0131 ve potansiyel FDA onaylar\u0131 b\u00fcy\u00fcmeyi destekliyor.<\/li>\n<li><strong>2028<\/strong>: 180-210$<br \/> Giri\u015fimsel glokom alan\u0131nda pazar liderli\u011fi peki\u015ftiriliyor.<\/li>\n<li><strong>2030<\/strong>: 250-300$<br \/> K\u00fcresel geni\u015fleme ve yeni \u00fcr\u00fcn hatt\u0131 ticarile\u015ftirmesi.<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Mevcut fiyat\u0131n i\u00e7sel de\u011fere %43 iskonto ile i\u015flem g\u00f6rmesi, uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc bir al\u0131m f\u0131rsat\u0131 sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>K\u00e2rl\u0131l\u0131k zamanlamas\u0131<\/strong>: H\u00e2l\u00e2 net zarar bildiriyor (-0,34$ GAAP EPS 2. \u00e7eyrekte)<\/li>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: Baz\u0131 b\u00f6lgelerde MAC geri \u00f6deme sorunlar\u0131<\/li>\n<li><strong>Pazar rekabeti<\/strong>: Oftalmoloji alan\u0131nda yerle\u015fik oyuncular<\/li>\n<li><strong>Volatilite<\/strong>: Beta 0,77 ancak Ocak zirvelerinden %44 d\u00fc\u015f\u00fc\u015f ya\u015fand\u0131<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Rekor b\u00fcy\u00fcme<\/strong>: Y\u0131ll\u0131k %30 gelir art\u0131\u015f\u0131 ile 124,1 milyon $<\/li>\n<li><strong>\u00dcr\u00fcn ba\u015far\u0131s\u0131<\/strong>: iDose TR yakla\u015f\u0131k 31 milyon $ \u00e7eyreklik sat\u0131\u015fla b\u00fcy\u00fck benimseme sa\u011fl\u0131yor<\/li>\n<li><strong>Rehberlik y\u00fckseltmesi<\/strong>: Y\u0131l sonu gelir tahmini 480-486 milyon $ olarak art\u0131r\u0131ld\u0131<\/li>\n<li><strong>Pazar liderli\u011fi<\/strong>: 1,64 milyar $\u2019l\u0131k k\u00fcresel glokom pazar\u0131nda \u00f6nc\u00fc<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc nakit<\/strong>: 500 milyon $ rezerv stratejik esneklik sa\u011fl\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Ortalama maliyetle al\u0131m<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: 3 Kas\u0131m\u2019\u0131 yak\u0131ndan takip edin\u2014kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015flerde al\u0131m yap\u0131n<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir b\u00fcy\u00fcme hikayesi, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li>\n<li><strong>Do\u011fru \u00e7e\u015fitlendirin<\/strong>: GKOS pay\u0131n\u0131z\u0131 portf\u00f6y\u00fcn\u00fcz\u00fcn %10\u2019unun alt\u0131nda tutun<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;GKOS ticareti g\u00f6z ameliyat\u0131 gibidir\u2014sabit eller ve m\u00fckemmel zamanlama gerektirir. Yanl\u0131\u015f anda k\u0131rparsan\u0131z f\u0131rsat\u0131 ka\u00e7\u0131rabilirsiniz!&#8221;<\/p>\n<h2>\u2705 Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Riske atmaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;GKOS&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece &#8220;Glaukos&#8221; de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131 ve toplam maliyeti i\u015flem \u00f6ncesi kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 herkes i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito<\/strong>: Sadece 5$ ile portf\u00f6y\u00fcn\u00fcz\u00fc olu\u015fturmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong>: Herhangi bir kimlik belgesi ile 1 dakikal\u0131k KYC<\/li>\n<li><strong>100+ para \u00e7ekme se\u00e7ene\u011fi<\/strong>: Kripto para ve d\u00fcnya \u00e7ap\u0131nda banka transferleri dahil<\/li>\n<li><strong>Par\u00e7al\u0131 hisseler<\/strong>: Pahal\u0131 hisselere k\u00fc\u00e7\u00fck miktarlarla yat\u0131r\u0131m yapabilirsiniz<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025\u2019te Glaukos: G\u00f6z Bak\u0131m\u0131nda Devrim<\/h2>\n<p>Glaukos Corporation, glokom, kornea bozukluklar\u0131 ve retina hastal\u0131klar\u0131n\u0131 hedefleyen be\u015f yenilik\u00e7i platformla oftalmoloji alan\u0131nda liderdir. \u015eirket, Mikro-\u0130nvaziv Glokom Cerrahisi (MIGS) \u00f6nc\u00fcs\u00fcd\u00fcr ve 1,64 milyar $\u2019l\u0131k k\u00fcresel glokom pazar\u0131nda liderli\u011fini s\u00fcrd\u00fcrmektedir.<\/p>\n<p><strong>2025 E\u011flenceli Ger\u00e7ek<\/strong>: Glaukos\u2019un iDose TR implant\u0131 \u00f6yle bir at\u0131l\u0131m ki, hacmin %80\u2019den fazlas\u0131 profesyonel \u00fccret tarifelerinin yerle\u015fik oldu\u011fu b\u00f6lgelerden geliyor\u2014cerrahlar, glokom hastalar\u0131 i\u00e7in g\u00fcnl\u00fck g\u00f6z damlas\u0131n\u0131 ortadan kald\u0131ran bu damlas\u0131z tedaviyi kullanmak i\u00e7in adeta s\u0131raya giriyor!<\/p>\n"},"faq":[{"question":"Glaukos Corporation hisseleri nereden al\u0131nabilir?","answer":"Glaukos Corporation (GKOS) hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Glaukos hisselerinin fiyat\u0131 nas\u0131l belirlenir?","answer":"Hisse fiyat\u0131 piyasa talebi ve arz\u0131na, \u015firketin finansal performans\u0131na, sekt\u00f6r trendlerine ve genel ekonomik ko\u015fullara ba\u011fl\u0131 olarak belirlenir."},{"question":"Glaukos Corporation'\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, iDose TR gibi yenilik\u00e7i \u00fcr\u00fcnlerle ve y\u0131ll\u0131k %30 gelir b\u00fcy\u00fcmesiyle 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme potansiyeline sahiptir."},{"question":"Yat\u0131r\u0131m yaparken hangi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131?","answer":"K\u00e2rl\u0131l\u0131k zamanlamas\u0131, reg\u00fclasyon belirsizlikleri, pazar rekabeti ve hisse volatilitesi gibi riskler dikkate al\u0131nmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar Glaukos hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"D\u00fczenli ve sabit miktarlarda yat\u0131r\u0131m yaparak, kazan\u00e7 raporlar\u0131n\u0131 takip ederek, uzun vadeli d\u00fc\u015f\u00fcnerek ve portf\u00f6y \u00e7e\u015fitlendirmesi yaparak yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Glaukos Corporation hisseleri nereden al\u0131nabilir?","answer":"Glaukos Corporation (GKOS) hisseleri, NYSE'de i\u015flem g\u00f6ren bir hisse senedidir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"Glaukos hisselerinin fiyat\u0131 nas\u0131l belirlenir?","answer":"Hisse fiyat\u0131 piyasa talebi ve arz\u0131na, \u015firketin finansal performans\u0131na, sekt\u00f6r trendlerine ve genel ekonomik ko\u015fullara ba\u011fl\u0131 olarak belirlenir."},{"question":"Glaukos Corporation'\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, iDose TR gibi yenilik\u00e7i \u00fcr\u00fcnlerle ve y\u0131ll\u0131k %30 gelir b\u00fcy\u00fcmesiyle 2025-2030 aras\u0131nda g\u00fc\u00e7l\u00fc bir b\u00fcy\u00fcme potansiyeline sahiptir."},{"question":"Yat\u0131r\u0131m yaparken hangi riskler g\u00f6z \u00f6n\u00fcnde bulundurulmal\u0131?","answer":"K\u00e2rl\u0131l\u0131k zamanlamas\u0131, reg\u00fclasyon belirsizlikleri, pazar rekabeti ve hisse volatilitesi gibi riskler dikkate al\u0131nmal\u0131d\u0131r."},{"question":"Yeni ba\u015flayanlar Glaukos hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"D\u00fczenli ve sabit miktarlarda yat\u0131r\u0131m yaparak, kazan\u00e7 raporlar\u0131n\u0131 takip ederek, uzun vadeli d\u00fc\u015f\u00fcnerek ve portf\u00f6y \u00e7e\u015fitlendirmesi yaparak yat\u0131r\u0131m yapmalar\u0131 \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-26T06:21:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T21:02:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-26T06:21:55+00:00\",\"dateModified\":\"2025-09-10T21:02:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"},\"wordCount\":18,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\",\"name\":\"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"datePublished\":\"2025-08-26T06:21:55+00:00\",\"dateModified\":\"2025-09-10T21:02:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/","og_locale":"tr_TR","og_type":"article","og_title":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-26T06:21:55+00:00","article_modified_time":"2025-09-10T21:02:57+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","type":"image\/webp"}],"author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-26T06:21:55+00:00","dateModified":"2025-09-10T21:02:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"wordCount":18,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/","name":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","datePublished":"2025-08-26T06:21:55+00:00","dateModified":"2025-09-10T21:02:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals7.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-glaukos-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Glaukos Corporation (GKOS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Glaukos Corporation (GKOS) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":351936,"slug":"how-to-buy-glaukos-corporation","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Glaukos Corporation (GKOS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-glaukos-corporation\/"},"pt_AA":{"locale":"pt_AA","id":351935,"slug":"how-to-buy-glaukos-corporation","post_title":"Como comprar a\u00e7\u00f5es da Glaukos Corporation (GKOS) - Investimento em a\u00e7\u00f5es da Glaukos Corporation (GKOS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-glaukos-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=351932"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351932\/revisions"}],"predecessor-version":[{"id":372666,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/351932\/revisions\/372666"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334045"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=351932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=351932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=351932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}